- Home
- ALEC vs DBI Comparison
ALEC vs DBI Comparison
Compare ALEC & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- DBI
- Stock Information
- Founded
- ALEC 2013
- DBI 1991
- Country
- ALEC United States
- DBI United States
- Employees
- ALEC N/A
- DBI N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- DBI Clothing/Shoe/Accessory Stores
- Sector
- ALEC Health Care
- DBI Consumer Discretionary
- Exchange
- ALEC Nasdaq
- DBI Nasdaq
- Market Cap
- ALEC 124.0M
- DBI 138.7M
- IPO Year
- ALEC 2019
- DBI 1991
- Fundamental
- Price
- ALEC $1.50
- DBI $3.68
- Analyst Decision
- ALEC Hold
- DBI Hold
- Analyst Count
- ALEC 9
- DBI 2
- Target Price
- ALEC $3.40
- DBI $4.50
- AVG Volume (30 Days)
- ALEC 4.6M
- DBI 534.1K
- Earning Date
- ALEC 11-06-2025
- DBI 12-09-2025
- Dividend Yield
- ALEC N/A
- DBI 5.43%
- EPS Growth
- ALEC N/A
- DBI N/A
- EPS
- ALEC N/A
- DBI N/A
- Revenue
- ALEC $81,130,000.00
- DBI $2,917,437,000.00
- Revenue This Year
- ALEC N/A
- DBI N/A
- Revenue Next Year
- ALEC $290.64
- DBI $2.53
- P/E Ratio
- ALEC N/A
- DBI N/A
- Revenue Growth
- ALEC 46.77
- DBI N/A
- 52 Week Low
- ALEC $0.87
- DBI $2.18
- 52 Week High
- ALEC $6.14
- DBI $6.29
- Technical
- Relative Strength Index (RSI)
- ALEC 27.08
- DBI 52.02
- Support Level
- ALEC $1.45
- DBI $3.35
- Resistance Level
- ALEC $1.60
- DBI $3.95
- Average True Range (ATR)
- ALEC 0.20
- DBI 0.17
- MACD
- ALEC -0.20
- DBI 0.04
- Stochastic Oscillator
- ALEC 8.45
- DBI 67.86
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.